Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

See if CBT-I can help with insulin resistance in adults with insomnia

Official title: Insomnia, Metabolic Syndrome and Insulin Resistance

Run by University of Missouri-Columbia · NCT07333586 · Data updated 2026-11-12

This study tests whether Cognitive Behavioral Therapy for Insomnia (CBT-I) can improve insulin resistance and metabolic measures in adults with insomnia.

More Insomnia trials

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Missouri-Columbia
Academic / other
Locations1 site (Columbia, Missouri)
StatusRecruiting
StartedSeptember 20, 2026
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT07333586 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18-50 with BMI 28-45 kg/m2 and an Insomnia Severity Index score of 15 or higher.

Probably not a fit

Individuals with contraindications to CBT-I, significant comorbidities, or those already receiving insomnia treatment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, 5-week study compares CBT-I to sleep hygiene in 20 adults ages 18-50 with insomnia and elevated BMI. Participants complete questionnaires and daily sleep logs before and after the intervention to assess sleep and metabolic outcomes, including insulin resistance and fasting glucose. The study uses CBT-I as the main treatment to address thoughts and behaviors around sleep, with sleep hygiene as a control condition. Outcomes will provide preliminary evidence on whether improving sleep can influence metabolic health in this population.

Why it matters

Potential benefit: If successful, participants may experience better sleep and potential improvements in insulin sensitivity and metabolic markers.

How similar studies have gone: Previous work suggests sleep improvement can influence metabolic outcomes, but findings are still emerging in this specific population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

ages 18-50 y BMI 28-45 kg/m2 Score on the Insomnia Severity Index ≥15.

Exclusion Criteria:

contraindications for CBT-I (mania or seizure disorder) symptoms requiring immediate attention (e.g., psychosis, suicide intent) report illicit substance use on a monthly basis (e.g., cocaine, opioids) receiving behavioral treatment for insomnia overt cardiovascular disease overt renal disease thyroid disease cancer pregnant dieting using GLP-1 agonists taking exogenous insulin

Where it's running

  • University of Missouri
    Columbia, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.